Ernexa Therapeutics (NASDAQ: ERNA) has announced it was selected as one of only ten global companies to participate in the prestigious Japan Entry Acceleration Program (JEAP) by the Japan External Trade Organization...
Eterna Therapeutics (NASDAQ:ERNA) has announced the appointment of Elena Ratner, MD, MBA, to its board of directors. The company states that Dr. Ratner will spearhead the strategic direction of Eterna’s efforts to...